Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» prostate cancer
prostate cancer
Can Zytiga Build on a Historic 2012?
Motley Fool
Wed, 02/20/13 - 11:40 am
Zytiga
JNJ
prostate cancer
Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC
Pipeline Review
Sun, 02/17/13 - 11:58 am
PSMA ADC
prostate cancer
Progenics Pharmaceuticals
J&J's Prostate Cancer Drug Zytiga Approved for Earlier Use in EU
Motley Fool
Sat, 01/12/13 - 11:04 am
JNJ
Zytiga
prostate cancer
Dendreon Rises on Optimism Over Cancer Drug Provenge
Bloomberg
Fri, 01/11/13 - 12:05 pm
Dendreon
prostate cancer
Provenge
Court rules against Medivation in fight with UCLA over cancer drug
Yahoo/Fly on the Wall
Mon, 12/24/12 - 10:40 am
Medivation
UCLA
Aragon
Xtandi
prostate cancer
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Big News for This Blockbuster Drug
Motley Fool
Sat, 12/15/12 - 11:27 am
JNJ
Zytiga
prostate cancer
Dendreon Dodges A Bullet
Seeking Alpha
Tue, 12/11/12 - 10:18 am
JNJ
Dendreon
Zytiga
prostate cancer
Provenge
FDA approves J&J's Zytiga for men who have not yet received chemotherapy for prostate tumors
Yahoo/AP
Tue, 12/11/12 - 08:17 am
FDA
JNJ
Zytiga
prostate cancer
After XTANDI's FDA Approval, Medivation Pulls Back
Seeking Alpha
Sat, 11/17/12 - 01:44 pm
Xtandi
Medivation
prostate cancer
Prostate Cancer Market Takes Shape - Part 1: Dendreon And Medivation
Seeking Alpha
Wed, 11/14/12 - 10:33 am
prostate cancer
Medivation
Dendreon
Provenge
JNJ
Sanofi
Zytiga, Xtandi will help pump prostate cancer market to $9.1B
Fierce Pharma
Tue, 11/13/12 - 05:45 pm
Xtandi
Zytiga
prostate cancer
JNJ
Medivation
Astellas
Medivation Prostate Cancer Drug Launches Hot
TheStreet.com
Thu, 11/1/12 - 11:50 am
Medivation
prostate cancer
Astellas
Xtandi
Physician bias in prostate cancer treatment? | MassDevice.com On Call
Mon, 10/15/12 - 07:12 pm
physicians
prostate cancer
cancer
prostate
treatment
Dendreon and Celgene Cancer Treatment Catalysts Face Rocky Road
Wall St. Cheat Sheet
Mon, 10/15/12 - 11:41 am
Celgene
Dendron
Provenge
prostate cancer
Opko's 4KScore Could Generate Over $1.8 Billion Annually
Seeking Alpha
Wed, 10/3/12 - 12:34 pm
GSK
JNJ
OPKO Health
Merck
Novartis
Pfizer
Sanofi
prostate cancer
4Kscore
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Yahoo/MarketWire
Sun, 09/30/12 - 10:34 am
Astellas
Medivation
Enzalutamide
prostate cancer
Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in Prostate Cancer Patients
Pipeline Review
Sat, 09/29/12 - 12:41 pm
Progenics
PSMA ADC
prostate cancer
Five-Cent Diabetes Pill From 1958 May Be New Cancer Drug
Bloomberg
Wed, 09/26/12 - 10:27 am
metformin
prostate cancer
Medivation Gets Surprise Early Approval For Prostate Cancer Pill
Seeking Alpha
Tue, 09/4/12 - 11:56 am
prostate cancer
Medivation
Xtandi
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
…
next ›
last »